PROTÉINES DE FUSION FOLLISTATINE-FC RECOMBINANTES ET LEUR UTILISATION DANS LE TRAITEMENT DE LA DYSTROPHIE MUSCULAIRE DE DUCHENNE

The present invention provides, among other things, methods and compositions for treating muscular dystrophy, in particular, Duchenne muscular dystrophy (DMD). In some embodiments, a method according to the present invention includes administering to an individual who is suffering from or susceptibl...

Full description

Saved in:
Bibliographic Details
Main Authors NORTON, Angela W, ISKENDERIAN, Andrea, SHEN, Chuan, PAN, Clark
Format Patent
LanguageFrench
Published 02.06.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides, among other things, methods and compositions for treating muscular dystrophy, in particular, Duchenne muscular dystrophy (DMD). In some embodiments, a method according to the present invention includes administering to an individual who is suffering from or susceptible to DMD an effective amount of a recombinant follistatin fusion protein such that at least one symptom or feature of DMD is reduced in intensity, severity, or frequency, or has delayed onset.
Bibliography:Application Number: MA20170043588